Literature DB >> 8777831

Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications.

R K Sundaram1, A Bhaskar, S Vijayalingam, M Viswanathan, R Mohan, K R Shanmugasundaram.   

Abstract

1. This study was conducted on 467 cases of non-insulin-dependent diabetes mellitus and 180 healthy controls. Lipid peroxidation products in plasma and erythrocytes were assayed as thiobarbituric acid reactive substances, along with the erythrocyte antioxidant enzymes, namely superoxide dismutase, catalase and glutathione peroxidase. In addition, scavenger vitamins A, C and E and reduced glutathione levels in blood were also measured. 2. Lipid peroxidation was significantly raised within the first 2 years of diagnosis, and superoxide dismutase, catalase, reduced glutathione and vitamins C and E were significantly lowered. 3. These changes were correlated with the duration of the disease and were of a higher magnitude with the development of complications. 4. The results suggest that the antioxidant deficiency and excessive peroxide-mediated damage may appear early on in non-insulin-dependent diabetes mellitus, before the development of secondary complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777831     DOI: 10.1042/cs0900255

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  49 in total

Review 1.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Age related changes in lipid peroxidation and antioxidants in elderly people.

Authors:  V Prashant Akila; H Harishchandra; Vivian D'souza; Benedicta D'souza
Journal:  Indian J Clin Biochem       Date:  2007-03

4.  Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients.

Authors:  Alliny de Souza Bastos; Dana T Graves; Ana Paula de Melo Loureiro; Carlos Rossa Júnior; Sâmia Cruz Tfaile Corbi; Fausto Frizzera; Raquel Mantuaneli Scarel-Caminaga; Niels Olsen Câmara; Oelisoa M Andriankaja; Meire I Hiyane; Silvana Regina Perez Orrico
Journal:  J Diabetes Complications       Date:  2016-07-21       Impact factor: 2.852

5.  Erythrocyte oxidant/antioxidant status of diabetic patients.

Authors:  S Büyükkoçak; H S Oztürk; M N Tamer; M Kaçmaz; M Y Cimen; I Durak
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

6.  [Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress].

Authors:  Christian Brinkmann; Robert H G Schwinger; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2011-03-07

Review 7.  Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.

Authors:  Kailash Prasad; Indu Dhar
Journal:  Int J Angiol       Date:  2014-12

8.  Antioxidant and Antidiabetic Activity of Helicteres isora (L.) Fruits.

Authors:  M Suthar; G S Rathore; A Pareek
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

9.  Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset.

Authors:  Octavian Savu; Ovidiu Marius Bradescu; Cristian Serafinceanu; Liviu Iosif; Constantin Ionescu Tirgoviste; Irina Stoian
Journal:  Redox Rep       Date:  2013-03-06       Impact factor: 4.412

10.  Effects of Melothria maderaspatana leaf extract on antioxidant status in sham-operated and uninephrectomized DOCA-salt hypertensive rats.

Authors:  Chinnadurai Veeramani; Balakrishnan Aristatile; Ganesan Pushpavalli; Kodukkur Viswanathan Pugalendi
Journal:  Saudi J Biol Sci       Date:  2010-05-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.